Erythropoietin in Hemolytic Uremic Syndrome

NCT03776851 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Hemolytic-Uremic Syndrome
Anemia

Interventions

DRUG: erythropoietin

Sponsor

Hospital General de Niños Pedro de Elizalde